JPMorgan Upgrades Alkermes (ALKS) to Overweight. PT $78
Tweet
Share
E-mail
Get Alerts ALKS Hot Sheet
Price: $48.87 +1.12%
Rating Summary:
17 Buy, 8 Hold, 3 Sell
Rating Trend:
Down
Today's Overall Ratings:
Up: 6 | Down: 7 | New: 77
Rating Summary:
17 Buy, 8 Hold, 3 Sell
Rating Trend:
Down
Today's Overall Ratings:
Up: 6 | Down: 7 | New: 77
Join SI Premium – FREE
JPMorgan upgraded Alkermes (NASDAQ: ALKS) from Neutral to Overweight with a price target of $78.00.
For an analyst ratings summary and ratings history on Alkermes click here. For more ratings news on Alkermes click here.
Shares of Alkermes closed at $43.51 yesterday.
Serious News for Serious Traders! Try StreetInsider.com Premium Free!
You May Also Be Interested In
- Wolfe Research Upgrades PulteGroup (PHM) to Outperform
- Alkermes narcolepsy drug data published in The Lancet Neurology
- Barclays Upgrades Segro PLC (SGRO:LN) (SEGXF) to Equalweight
Create E-mail Alert Related Categories
Hot Upgrades, UpgradesRelated Entities
JPMorganSign up for StreetInsider Free!
Receive full access to all new and archived articles, unlimited portfolio tracking, e-mail alerts, custom newswires and RSS feeds - and more!
